All Stories

  1. Enhanced antimicrobial activity of naringin-ciprofloxacin combination against Pseudomonas aeruginosa PAO1: Unveiling quorum-sensing mediated molecular mechanisms in biofilm formation and virulence

    Article • The Microbe, December 2024, Elsevier

    Dr Debaprasad Parai

  2. One Health intervention for elimination of anthrax in an endemic district of Odisha: A baseline and endline study

    Article • One Health, June 2024, Elsevier

    Debdutta Bhattacharya, Dr Debaprasad Parai

  3. Essential Oils as Alternative Antimicrobials: Current Status

    Article • Recent Advances in Anti-Infective Drug Discovery, April 2024, Bentham Science Publishers

    DESH DEEPAK SINGH, Dr Debaprasad Parai

  4. Evaluation of Antibacterial and Antibiofilm Activities of Fennel Seed Extract Against Methicillin-resistant Staphylococcus aureus

    Article • Current Bioactive Compounds, February 2024, Bentham Science Publishers

    Dr Debaprasad Parai, DESH DEEPAK SINGH

  5. Social and biological evaluation of antimicrobial resistance (SOBEAR) in rural India: a study protocol

    Article • Frontiers in Public Health, February 2024, Frontiers

    Debdutta Bhattacharya, Dr Debaprasad Parai

  6. Suspected human anthrax outbreak investigation in a tribal village of Koraput, India, 2021

    Article • Public Health Challenges, December 2023, Wiley

    Dr Debaprasad Parai, Debdutta Bhattacharya

  7. Investigation of human anthrax outbreak in Koraput district of Odisha, India

    Article • Travel Medicine and Infectious Disease, November 2023, Elsevier

    Debdutta Bhattacharya, Dr Debaprasad Parai

  8. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey

    Article • Rheumatology International, October 2023, Springer Science + Business Media

    Debdutta Bhattacharya, Dr Debaprasad Parai

  9. Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India

    Article • The Journal of Infection in Developing Countries, September 2023, Journal of Infection in Developing Countries

    Debdutta Bhattacharya, Dr Debaprasad Parai

  10. The aftermath of corona virus disease on antimicrobial resistance across low- and middle-income countries

    Article • Universitas Scientiarum, June 2023, Editorial Pontificia Universidad Javeriana

    Dr Debaprasad Parai

  11. COVID-19 vaccine hesitancy among school children aged 12-14 years: A cross-sectional study from Bhubaneswar, Odisha, India

    Article • The Journal of Infection in Developing Countries, May 2023, Journal of Infection in Developing Countries

    Debdutta Bhattacharya, Dr Debaprasad Parai

  12. PERSISTENCE AND DYNAMICITY OF SARS-COV-2 ANTIBODY RESPONSE AFTER DOUBLE DOSE OF BBV-152 AND AZD1222 VACCINES: A PROSPECTIVE, LONGITUDINAL, YEAR-LONG COHORT STUDY

    Article • International Journal of Infectious Diseases, May 2023, Elsevier

    Dr Debaprasad Parai

  13. Hepatitis B virus infection among the tribal and particularly vulnerable tribal population from an eastern state of India: Findings from the serosurvey in seven tribal dominated districts, 2021–2022

    Article • Frontiers in Microbiology, March 2023, Frontiers

    Dr Debaprasad Parai, Debdutta Bhattacharya

  14. Perception and determinants leading to antimicrobial (mis)use: A knowledge, attitude, and practices study in the rural communities of Odisha, India

    Article • Frontiers in Public Health, January 2023, Frontiers

    Dr Debaprasad Parai, Debdutta Bhattacharya

  15. Association of Probiotics and Prebiotics with Human Microbiome and the Functioning of Immune System

    Article • January 2023, Springer Science + Business Media

    Dr Debaprasad Parai

  16. Seroprevalence of human brucellosis among the tribal and non-tribal population residing in an eastern state of India: Findings from the state-wide serosurvey

    Article • Frontiers in Microbiology, November 2022, Frontiers

    Dr Debaprasad Parai, Debdutta Bhattacharya

  17. Seroprevalence of SARS-CoV-2 in patients with rheumatic diseases on disease modifying antirheumatic drugs and /or immunosuppressive medications from India: a multicentric study

    Article • October 2022, Research Square

    Dr Debaprasad Parai

  18. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance

    Article • npj Biofilms and Microbiomes, August 2022, Springer Science + Business Media

    Dr Debaprasad Parai, Debdutta Bhattacharya

  19. Scrub typhus seroprevalence from an eastern state of India: findings from the state-wide serosurvey

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, August 2022, Oxford University Press (OUP)

    Dr Debaprasad Parai, Debdutta Bhattacharya

  20. Dynamicity and persistence of severe acute respiratory syndrome coronavirus-2 antibody response after double dose and the third dose with BBV-152 and AZD1222 vaccines: A prospective, longitudinal cohort study

    Article • Frontiers in Microbiology, August 2022, Frontiers

    Dr Debaprasad Parai, Debdutta Bhattacharya

  21. Assessment of socio-behavioural correlates and risk perceptions regarding anthrax disease in tribal communities of Odisha, Eastern India

    Article • BMC Infectious Diseases, January 2022, Springer Science + Business Media

    Debdutta Bhattacharya, Dr Debaprasad Parai

  22. Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India

    Article • Epidemiology and Infection, January 2022, Cambridge University Press

    Debdutta Bhattacharya, Dr Debaprasad Parai

  23. Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave

    Article • International Journal of Microbiology Research, January 2022, Medknow

    Dr Debaprasad Parai, Debdutta Bhattacharya

  24. Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India

    Article • International Journal of Microbiology Research, January 2022, Medknow

    Dr Debaprasad Parai, Debdutta Bhattacharya

  25. Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines

    Article • Frontiers in Medicine, December 2021, Frontiers

    Debdutta Bhattacharya, Dr Debaprasad Parai

  26. Quorum Sensing Inhibitors from Natural Products: A New Anti-infective Approach

    Article • November 2021, Bentham Science Publishers

    Dr Debaprasad Parai

  27. Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection

    Article • Travel Medicine and Infectious Disease, November 2021, Elsevier

    Debdutta Bhattacharya, Dr Debaprasad Parai

  28. COVID-19 in children in Odisha state, India: a retrospective review

    Article • BMJ Paediatrics Open, November 2021, BMJ

    Debdutta Bhattacharya, Dr Debaprasad Parai

  29. SARS-CoV-2 IgG antibody responses in rt-PCR-positive cases: first report from India

    Article • Access Microbiology, October 2021, Society for General Microbiology

    Dr Debaprasad Parai

  30. Breakthrough SARS‐CoV‐2 infections among BBV‐152 (COVAXIN®) and AZD1222 (COVISHIELD TM ) recipients: Report from the eastern state of India

    Article • Journal of Medical Virology, October 2021, Wiley

    Debdutta Bhattacharya, Dr Debaprasad Parai

  31. IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection

    Article • Infection, July 2021, Springer Science + Business Media

    Debdutta Bhattacharya, Dr Debaprasad Parai

  32. Pooled testing for SARS‐CoV‐2 infection in an automated high‐throughput platform

    Article • Journal of Clinical Laboratory Analysis, June 2021, Wiley

    Debdutta Bhattacharya, Dr Debaprasad Parai

  33. Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies

    Article • Journal of Virological Methods, June 2021, Elsevier

    Debdutta Bhattacharya, Dr Debaprasad Parai

  34. One Health approach for elimination of human anthrax in a tribal district of Odisha: Study protocol

    Article • PLOS One, May 2021, PLOS

    Debdutta Bhattacharya, Dr Debaprasad Parai

  35. Effect of a single-dose of BBV-152 and AZD1222 on Spike antibody titre among healthcare workers previously infected with SARS-CoV-2

    Article • May 2021, Research Square

    Dr Debaprasad Parai

  36. Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India

    Article • Scientific Reports, May 2021, Springer Science + Business Media

    Debdutta Bhattacharya, Dr Debaprasad Parai

  37. IgG antibody response against Nucleocapsid and Spike protein post SARS-CoV-2 infection

    Article • May 2021, Research Square

    Dr Debaprasad Parai

  38. Seroprevalence of IgG antibody against SARS-CoV-2 among health care workers of anaesthesia departments from various hospital settings in India

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Debdutta Bhattacharya, Dr Debaprasad Parai

  39. A qualitative exploratory study using One Health approach for developing an intervention package for elimination of human anthrax in an endemic district of Odisha, India

    Article • International Journal of Microbiology Research, January 2021, Medknow

    Debdutta Bhattacharya, Dr Debaprasad Parai

  40. Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys

    Article • Epidemiology and Infection, January 2021, Cambridge University Press

    Debdutta Bhattacharya, Dr Debaprasad Parai

  41. Biofilm: A Challenge to Overcome in Wound Healing

    Article • January 2021, Springer Science + Business Media

    Dr Debaprasad Parai

  42. Saliva for diagnosis of SARS‐CoV‐2: First report from India

    Article • Journal of Medical Virology, December 2020, Wiley

    Sidhartha Giri, Debdutta Bhattacharya, Dr Debaprasad Parai

  43. A rare hetero-bimetallic Zn(II)/Ca(II) Schiff base complex: Synthesis, crystal structure, DFT, molecular docking and unveiling antimicrobial activity

    Article • Journal of Molecular Structure, December 2020, Elsevier

    Dr Debaprasad Parai

  44. Antimicrobial Peptides: An Approach to Combat Resilient Infections

    Article • Current Drug Discovery Technologies, September 2020, Bentham Science Publishers

    Dr Debaprasad Parai, Pia Dey

  45. DFT investigations of linear Zn3-type complex with compartmental N/O-donor Schiff base: Synthesis, characterizations, crystal structure, fluorescence and molecular docking

    Article • Journal of Molecular Structure, June 2020, Elsevier

    Dr Debaprasad Parai

  46. Role of Multidrug Resistance Proteins in Nonresponders to Immunomodulatory Therapy for Noninfectious Uveitis

    Article • Translational Vision Science & Technology, April 2020, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Debaprasad Parai

  47. Naringin sensitizes the antibiofilm effect of ciprofloxacin and tetracycline against Pseudomonas aeruginosa biofilm

    Article • International Journal of Medical Microbiology, April 2020, Elsevier

    Dr Debaprasad Parai

  48. Reserpine attenuates biofilm formation and virulence of Staphylococcus aureus

    Article • Microbial Pathogenesis, January 2020, Elsevier

    Dr Debaprasad Parai

  49. Antibiofilm and antivirulence property of reserpine.

    Article • Biofouling, February 2018, Taylor & Francis

    Dr Debaprasad Parai, Pia Dey

  50. Andrographolide induces oxidative stress-dependent cell death in unicellular protozoan parasite Trypanosoma brucei

    Article • Acta Tropica, December 2017, Elsevier

    Dr Debaprasad Parai

  51. Attenuation of Pseudomonas aeruginosa quorum sensing, virulence and biofilm formation by extracts of Andrographis paniculata

    Article • Microbial Pathogenesis, December 2017, Elsevier

    Dr Debaprasad Parai

  52. Bacterial biofilm eradication by Bacoside A

    Article • Canadian Journal of Microbiology, February 2017, Canadian Science Publishing

    Dr Debaprasad Parai

  53. Andrographolide: antibacterial activity against common bacteria of human health concern and possible mechanism of action

    Article • Folia Microbiologica, January 2017, Springer Science + Business Media

    Dr Debaprasad Parai